Japan is nearing approval for a pair of highly anticipated gene therapies but a debate over health care costs seems sure to follow amid the anticipated growth of such expensive treatments. httpss.nikkei.com2E2xyHFÂ
Japan is nearing approval for a pair of highly anticipated gene therapies, but a debate over health care costs seems sure to follow amid the anticipated growth of such expensive treatments. https://s.nikkei.com/2E2xyHF
More From BioPortfolio on "Japan is nearing approval for a pair of highly anticipated gene therapies, but a debate over health care costs seems sure to follow amid the anticipated growth of such expensive treatments. https://s.nikkei.com/2E2xyHF "